June 27, 2016
New study finds PAM a reliable and valid measure for the inpatient hospital setting
A new study published in Patient Education and Counseling Journal confirms that patients with unplanned hospital admissions were more likely to have low activation when compared to patients with planned admissions.
- The Patient Activation Measure® (PAM®) survey is a reliable and valid measure for use in the inpatient setting.
- Type of admission is an important predictor of patient activation.
- Measuring patient activation can allow for tailored care strategies in the hospital.
The purposes of this paper are to describe the internal consistency reliability and construct validity of the PAM-13 for hospitalized cardiology and oncology patients and to examine the predictors of low patient activation in the same population.
We evaluated the internal consistency reliability of the PAM-13 survey in the inpatient setting. Construct validity of the PAM-13 survey was then assessed using two approaches: expected known-groups differences between patients with planned and unplanned admissions PAM-13 levels and convergence of PAM-13 levels with other measures.
The PAM survey demonstrated adequate internal consistency overall (Cronbach α = 0.81). Patients with unplanned admissions were more likely to have low activation than patients with planned admissions (adjusted OR = 5.7, p = 0.008). The PAM-13 was modestly correlated (p < 0.001) with each of the PROMIS Global Health components used in this study (global, physical and mental health).
This study demonstrates the PAM-13 is a reliable and valid measure for use in the inpatient hospital setting and that type of admission (planned versus unplanned) is an important predictor of patient activation.
By measuring patient activation with the PAM-13, clinicians and researchers can provide tailored communication and care strategies to meet patient’s needs.